Cargando…

CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

BACKGROUND: Cyclin D1 (CCND1) has been associated with chemotherapy resistance and poor prognosis. In this study, we tested the hypothesis that CCND1 expression determines response and clinical outcomes in locally advanced head and neck squamous cell carcinoma (HNSCC) patients treated with neoadjuva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zhien, Guo, Wei, Zhang, Chenping, Xu, Qin, Zhang, Ping, Sun, Jian, Zhu, Hanguang, Wang, Zhonghe, Li, Jiang, Wang, Lizhen, Wang, Bingshun, Ren, Guoxin, Ji, Tong, Tu, Wenyong, Yang, Xihu, Qiu, Weiliu, Mao, Li, Zhang, Zhiyuan, Chen, Wantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204964/ https://www.ncbi.nlm.nih.gov/pubmed/22065993 http://dx.doi.org/10.1371/journal.pone.0026399

Ejemplares similares

Dose Dependent Activation of Retinoic Acid-Inducible Gene-I Promotes Both Proliferation and Apoptosis Signals in Human Head and Neck Squamous Cell Carcinoma
por: Hu, Jingzhou, et al.
Publicado: (2013)

Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: An in vitro study
por: Ren, Guoxin, et al.
Publicado: (2017)

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
por: Zhang, Ping, et al.
Publicado: (2006)

The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway
por: Xu, Qiaoshi, et al.
Publicado: (2020)

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma
por: Cao, Wei, et al.
Publicado: (2016)

Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma
por: ZHANG, MINGBIN, et al.
Publicado: (2013)

CD147 promotes progression of head and neck squamous cell carcinoma via NF‐kappa B signaling
por: Yu, Binbin, et al.
Publicado: (2018)

Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO
por: Jiang, Canhua, et al.
Publicado: (2007)

Nomogram model to predict postoperative infection after mandibular osteoradionecrosis surgery
por: Liu, Zhonglong, et al.
Publicado: (2017)

A Novel Tumor Suppressor SPINK5 Serves as an Independent Prognostic Predictor for Patients with Head and Neck Squamous Cell Carcinoma
por: Lv, Zhongjing, et al.
Publicado: (2020)

Tumor Suppressor LINC02487 Inhibits Oral Squamous Cell Carcinoma Cell Migration and Invasion Through the USP17–SNAI1 Axis
por: Feng, Lu, et al.
Publicado: (2020)

Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma
por: Huang, Dan, et al.
Publicado: (2003)

Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma
por: Liu, Shuli, et al.
Publicado: (2017)

Caveolin‐1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma
por: Lu, Tingwei, et al.
Publicado: (2021)

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma()()
por: Xu, Qiaoshi, et al.
Publicado: (2016)

A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma
por: Zhang, Chengyao, et al.
Publicado: (2020)

Intratumoral CD103(+)CD8(+) T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
por: Ren, Siqi, et al.
Publicado: (2023)

Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

Tricholemmal carcinoma of the head and neck region: A report of 15 cases
por: FENG, ZHIEN, et al.
Publicado: (2014)

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
por: Liu, Shuli, et al.
Publicado: (2020)

Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma
por: Xu, Xing, et al.
Publicado: (2021)

Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7
por: Yu, Binbin, et al.
Publicado: (2018)

LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus
por: Jiang, Yingying, et al.
Publicado: (2019)

A retrospective study of six patients with mandibular metastatic carcinoma
por: CAI, ZHEN, et al.
Publicado: (2016)

An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma
por: Bai, Guo, et al.
Publicado: (2023)

Identification of a Prognostic Pyroptostic-Related Model for Head and Neck Squamous Cell Carcinoma Based on LASSO-Cox Regression Analysis
por: Wu, Donglei, et al.
Publicado: (2022)

CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo
por: Feng, Yifei, et al.
Publicado: (2019)

Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
por: Wang, Kai, et al.
Publicado: (2023)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes
por: Cui, Zhibin, et al.
Publicado: (2013)

Long‐term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study
por: Dou, Shengjin, et al.
Publicado: (2020)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

Postoperative Complications of Free Flap Reconstruction in Moderate-Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study Based on Real-World Data
por: Li, Delong, et al.
Publicado: (2022)

circRNA circ‐CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR‐646
por: Zang, Yanzi, et al.
Publicado: (2020)

Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma
por: Zhang, Tingting, et al.
Publicado: (2021)

Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma
por: Xu, Qin, et al.
Publicado: (2008)

Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas
por: Chien, Huei-Tzu, et al.
Publicado: (2019)

An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2019)

Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
por: Xie, Furong, et al.
Publicado: (2015)

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
por: Hanna, Glenn J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nvn56h0vrl4m3gooepor5dl3k3